Search

Search Constraints

You searched for: Author/Creator Gamis, Alan

Search Results

1. Comparison of administrative/billing data to expected protocol‐mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Issue 7 (11th March 2015)

2. Comparison of in‐patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group. Issue 10 (6th May 2015)

3. Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group. Issue 1 (2nd September 2021)

4. Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group. (20th May 2013)

5. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients. Issue 23 (19th September 2013)

6. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: A Report from the Children's Oncology Group. Issue 23 (19th September 2013)

7. Early discharge as a mediator of greater ICU‐level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report. (29th July 2016)

8. Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Issue 1 (December 2016)

9. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group. Issue 1 (January 2017)

10. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Issue 1 (December 2015)